A Look at Company Efforts to Enhance Clinical Trial Diversity

 

Graphic of a piece of paper showing circles and text-like objects

PhRMA member companies are taking individual steps to build trust and encourage broader, more diverse clinical trial participation. A recent survey of many PhRMA members found 97% of respondents reported specific measures they’re taking to address access issues for clinical trial participants. In the pages of this report, you’ll find dozens of case studies covering this work. 

Graphic of a piece of paper showing circles and text-like objects